2 versions

CosmeticWhat changed in PLACED ON CALENDAR SENATEcompared with INTRODUCED IN SENATE (Jun 17, 2026)

Technical corrections only. The later version, v2, includes an additional co-sponsor and reflects the procedural update of the resolution being discharged from committee and placed on the calendar. No substantive changes were made to the text of the joint resolution.

S.J.Res. 197119th CongressIntroduced Jun 17, 2026

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program".

Senate Committee DischargedHealthMajor

View bill text

Sponsor: Sen. Baldwin, Tammy [D-WI]
Committees: Health, Education, Labor, and Pensions Committee (primary)
Last action: Sep 29, 2026

Bottom line

S.J. Res. 197 is a legislative attempt to block a 2027 health insurance market rule from CMS, effectively maintaining the status quo or reverting to prior regulations for Affordable Care Act (ACA) benefit and payment parameters.

What it actually does

This joint resolution seeks to nullify a specific rule issued by the Centers for Medicare & Medicaid Services (CMS) of the Department of Health and Human Services (HHS). The rule, titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program," would be prevented from taking effect if this resolution is enacted, effectively blocking its implementation.

Proponents argue

Proponents of this resolution argue that the CMS rule is detrimental, exceeds agency authority, or implements policies that are not in the best interest of patients or the healthcare system. They might contend that the rule imposes undue burdens, increases costs, or undermines the stability of the ACA markets, making its disapproval necessary for proper regulatory oversight and consumer protection.

Opponents contend

Opponents of this resolution (i.e., those who support the CMS rule) would argue that the rule is necessary to stabilize health insurance markets, improve patient protections, or ensure the efficient operation of the Affordable Care Act. They would likely assert that the rule provides essential updates for 2027 benefit and payment parameters and supports the Basic Health Program, and its disapproval would create regulatory uncertainty or harm beneficiaries.

The bill text is extremely short and straightforward, requiring less than a minute to read, making it highly accessible for immediate understanding.

Resolved by the Senate and House of Representatives of the United States of America in Congress assembled, That Congress disapproves...

Disapproval of CMS Rule on 2027 ACA Benefit and Payment Parameters

prominently featuredstraightforward

This provision explicitly states that Congress disapproves of the rule submitted by the Centers for Medicare & Medicaid Services (CMS) concerning the "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program." If enacted, this resolution would prevent the specified CMS rule (91 Fed. Reg. 29526 (May 20, 2026)) from having any legal force or effect, effectively nullifying it and preventing the agency from issuing a substantially similar rule in the future.

GroupImpactMechanismScale

GroupCenters for Medicare & Medicaid Services (CMS)ImpactLoss of regulatory authority for the specific ruleMechanismCongressional disapproval under the Congressional Review Act (CRA)ScaleSpecific to one rule

GroupHealth insurance issuersImpactUncertainty or change in regulatory environmentMechanismThe rule's provisions regarding benefit and payment parameters for 2027 would not take effect, potentially reverting to prior regulations or creating a void in guidance.ScaleBroad impact on ACA market operations

GroupConsumers (patients, enrollees in ACA plans)ImpactPotential changes to benefits, costs, or program structureMechanismThe specific details of the disapproved CMS rule would not apply, leading to different standards for plans, potentially affecting coverage, out-of-pocket costs, or access to care.ScaleMillions of individuals

GroupStates operating Basic Health ProgramsImpactImpact on program parameters or fundingMechanismThe rule's provisions related to the Basic Health Program would not take effect, potentially altering how these programs operate or are funded.ScaleStates with Basic Health Programs and their beneficiaries

Supporters argue

Supporters of the resolution argue that the CMS rule is either overreaching, poorly designed, or detrimental to the healthcare system, and its disapproval is necessary to protect consumers or ensure proper regulatory oversight. They might contend that the rule introduces unnecessary complexities or costs that would ultimately harm patients or destabilize markets.

Critics contend

Opponents of the resolution (i.e., proponents of the CMS rule) would argue that the rule is a carefully considered update essential for the functioning of the ACA markets in 2027. They would assert that disapproving it would create regulatory uncertainty, disrupt planning for health plans, and potentially harm consumers by removing beneficial updates or protections.

Tradeoffs

The resolution presents a tension between congressional oversight of agency rulemaking and the executive branch's authority to implement and update regulations for complex programs like the Affordable Care Act. It also highlights differing views on the optimal regulatory framework for health insurance markets and the Basic Health Program, balancing regulatory stability with congressional accountability.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.